ANTX   $4.49  6.90% Market Open

AN2 Therapeutics, Inc.

EMA (20): 2026-05-28 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-06-05 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2026-03-04 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -13.68%
EMA (20) date of signal May 28, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield 0.79%
EMA (50) date of signal June 5, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 187.31%
EMA (100) date of signal March 4, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal June 8, 2026, 3 a.m.
MACD Signals bearish
MACD Yield 0.79%
MACD date of signal June 5, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.0
Stochastic date of signal June 8, 2026, 3 a.m.
Updated June 10, 2026, 11 p.m.